Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors

Ling Ma; Yali Li; Ting Shi; Zhiling Zhu; Jianyuan zhao; Yongli Xie; Jiajia Wen; Saisai Guo; Jing Wang; Jiwei Ding; Chen Liang; Guangzhi Shan; Quanjie Li; Mei Ge; Shan Cen

doi:10.1016/j.biopha.2023.114213

Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors

Ling Ma
, Yali Li
, Ting Shi
, Zhiling Zhu
, Jianyuan zhao
, Yongli Xie
, Jiajia Wen
, Saisai Guo
, Jing Wang
, Jiwei Ding
, Chen Liang
, Guangzhi Shan
, Quanjie Li
, Mei Ge
, Shan Cen

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College
Shanghai Laiyi Center for Biopharmaceutical R&D
State Key Laboratory of Microbial Metabolism
Lady Davis Institute-Jewish General Hospital

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	114213
Journal	Biomedicine and Pharmacotherapy
Volume	158
DOIs	https://doi.org/10.1016/j.biopha.2023.114213
State	Published - Feb 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

Pharmacology

Keywords

Angiotensin converting enzyme 2
Entry inhibitor
SARS-CoV-2
Spike protein
Teicoplanin

Access to Document

10.1016/j.biopha.2023.114213

Cite this

@article{e7b36a1fe15d4bf19f6e2acd87c27491,

title = "Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors",

keywords = "Angiotensin converting enzyme 2, Entry inhibitor, SARS-CoV-2, Spike protein, Teicoplanin",

author = "Ling Ma and Yali Li and Ting Shi and Zhiling Zhu and Jianyuan zhao and Yongli Xie and Jiajia Wen and Saisai Guo and Jing Wang and Jiwei Ding and Chen Liang and Guangzhi Shan and Quanjie Li and Mei Ge and Shan Cen",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2023",

month = feb,

doi = "10.1016/j.biopha.2023.114213",

language = "English",

volume = "158",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

}

TY - JOUR

T1 - Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors

AU - Ma, Ling

AU - Li, Yali

AU - Shi, Ting

AU - Zhu, Zhiling

AU - zhao, Jianyuan

AU - Xie, Yongli

AU - Wen, Jiajia

AU - Guo, Saisai

AU - Wang, Jing

AU - Ding, Jiwei

AU - Liang, Chen

AU - Shan, Guangzhi

AU - Li, Quanjie

AU - Ge, Mei

AU - Cen, Shan

PY - 2023/2

Y1 - 2023/2

KW - Angiotensin converting enzyme 2

KW - Entry inhibitor

KW - SARS-CoV-2

KW - Spike protein

KW - Teicoplanin

UR - https://www.scopus.com/pages/publications/85145820856

UR - https://www.scopus.com/pages/publications/85145820856#tab=citedBy

U2 - 10.1016/j.biopha.2023.114213

DO - 10.1016/j.biopha.2023.114213

M3 - Article

C2 - 36916436

AN - SCOPUS:85145820856

SN - 0753-3322

VL - 158

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

M1 - 114213

ER -

Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors

UN SDGs

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this